CD36 has been related to cell proliferation and tumor growth kinetics in several types of cancers (Deng et al., 2019; Watt et al., 2019; Drury et al., 2020; Ghoneum et al., 2020; Sakurai et al., 2020; Gyamfi et al., 2021; Haidari et al., 2021; Luo et al., 2021; Drury et al., 2022). Here, CD36 is linked to cancer.